SPONSOR
Xinqiao Hospital of Chongqing
Total Trials
4
Recruiting
4
Phases
Phase 2, Phase 3, Phase 2, Phase 3
Conditions studied: Nasopharyngeal CarcinomaStroke, Acute IschemicLung CancerImmune Checkpoint InhibitorRadiotherapy
Xinqiao Hospital of Chongqing is a clinical research sponsor with 4 registered studies on ClinicalTrials.gov, of which 4 are actively recruiting participants. Research covers conditions including Nasopharyngeal Carcinoma, Stroke, Acute Ischemic, Lung Cancer, Immune Checkpoint Inhibitor.
The trial portfolio spans Phase 2, Phase 3, Phase 2, Phase 3 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Xinqiao Hospital of Chongqing
How many clinical trials has Xinqiao Hospital of Chongqing sponsored?
ClinicalMetric currently tracks 4 clinical trials sponsored by Xinqiao Hospital of Chongqing, of which 4 are actively recruiting participants. These trials cover conditions including Nasopharyngeal Carcinoma, Stroke, Acute Ischemic, Lung Cancer. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Xinqiao Hospital of Chongqing research focus on?
Xinqiao Hospital of Chongqing clinical trials span Nasopharyngeal Carcinoma, Stroke, Acute Ischemic, Lung Cancer, Immune Checkpoint Inhibitor, Radiotherapy. The research pipeline includes Phase 2, Phase 3, Phase 2, Phase 3 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Xinqiao Hospital of Chongqing clinical trial?
To participate in a Xinqiao Hospital of Chongqing trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Xinqiao Hospital of Chongqing trials with current recruitment status updated daily.
Clinical Trials by Xinqiao Hospital of Chongqing
NCT05147844 Phase 2
Recruiting
Toripalimab Combined With Radiotherapy in the Treatment of Oligometastatic Nasopharyngeal Carcinoma
Nasopharyngeal Carcinoma
NCT06987305 Phase 3
Recruiting
Intravenous rhTNK-tPA Before Stroke Thrombectomy in the Extended Time Window
Stroke, Acute Ischemic
NCT05728333 Phase 2, Phase 3
Recruiting
Intravenous Tirofiban Versus Alteplase Before Mechanical Thrombectomy in Stroke
Stroke, Acute Ischemic
NCT05754203
Recruiting
Efficacy and Safety of Super-hyperfractionation Pulse Radiotherapy Combined With ICIs for Advanced NSCLC
Lung Cancer
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology